Psynova Neurotech Ltd.
St. John's Innovation Centre; Cowley Rd.,
Psynova Neurotech was established in 2005 by Dr Sabine Bahn, MD, PhD, MRCPsych, and Prof Chris Lowe, PhD of the University of Cambridge to build on 12 years of ground-breaking research by Dr Bahn in identifying novel biomarkers for neuropsychiatric illnesses. Psynova is collaborating with Rules Based Medicine (RBM) Inc. to co-develop a candidate biomarker panel into a clinical test to aid in the early diagnosis and treatment of schizophrenia. Psynova expects this will be the first of several products in related therapeutic areas to address this unmet clinical need for objective molecular tests in psychiatric disorders. Psynova is also the co-ordinator of an 8 member consortium that has been awarded a European Commission Framework 7 grant to develop minimally invasive, high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders.